SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EZLibra who wrote (3498)3/20/2000 11:16:00 PM
From: GregSL  Read Replies (1) of 3702
 
"A spokeswoman for Techniclone said on Monday that a Phase III trial will be launched in the second quarter of this year."

I think Reuters confused Phase I and Phase III. The study they are referring to is probably the new Phase I Oncolym study. Looking at the quality of the rest of the article, I wouldn't be surprised if Reuters made the mistake here.

I doubt that Cotara will be ready for Phase III next quarter. They had only enrolled 9 patients as of last October. Does anybody know the current numbers for the Glioma and Mexico City trials?

Still long,
Greg
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News